BioTech/Drugs - Bryn Mawr, PA, US
Opsidio, a preclinical stage biotechnology company that develops novel biologic therapeutics for patients suffering from fibrotic and allergic diseases. Our lead candidate, OpSCF targets the unique form of Stem Cell Factor (SCF) that drives the cascade of pro fibrotic cytokines that may lead to organ failure and death.
Outlook
Varnish
Wix
Google Cloud Hosting
Mobile Friendly